- 180-day grace period granted to Aptorum Group (APM, Financial) to regain compliance with Nasdaq listing requirements.
- Trading of APM shares on Nasdaq will continue uninterrupted during this period.
- A reverse stock split is under consideration to address compliance issues.
Aptorum Group Limited (APM), a biotechnology company, announced it has received a notification from Nasdaq Stock Market regarding its non-compliance with the minimum bid price requirement of $1 per share, according to Nasdaq Listing Rule 5550(a)(2). The notification, dated April 15, 2025, grants Aptorum Group a 180-calendar-day grace period, expiring on October 14, 2025, to regain compliance with Nasdaq's continued listing standards.
The company emphasized that during the grace period, trading of its APM shares on the Nasdaq will continue without any disruptions. Aptorum Group is actively considering various strategies to restore compliance, including potentially executing a reverse stock split to increase its stock price. The company remains committed to maintaining its listing on Nasdaq and will take necessary actions within the allotted timeframe.
Aptorum Group Limited focuses on discovering, developing, and commercializing therapeutic assets to address diseases with unmet medical needs. The company has reiterated its commitment to its strategic goals and regulatory compliance to ensure continued growth and stability in the market.
